Entegris (ENTG) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Entegris (ENTG) reported revenue of $807.1 million, down 0.1% over the same period last year. EPS came in at $0.72, compared to $0.77 in the year-ago quarter.The reported revenue represents a surprise of +0.29% over the Zacks Consensus Estimate of $804.74 million. With the consensus EPS estimate being $0.72, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Entegris performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net sales- Materials Solutions (MS): $348.6 million compared to the $361.78 million average estimate based on two analysts. The reported number represents a change of +0.6% year over year.Net sales- Advanced Purity Solutions (APS): $460.8 million versus the two-analyst average estimate of $447.4 million.Adjusted segment profit- Materials Solutions (MS): $65.9 million versus $77.59 million estimated by two analysts on average.Adjusted segment profit- Advanced Purity Solutions (APS): $119.2 million versus $111.07 million estimated by two analysts on average.View all Key Company Metrics for Entegris here>>>Shares of Entegris have returned +0.6% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Entegris, Inc. (ENTG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks